It was originally developed at the Wellcome Trust Sanger Institute to bundle a FASTA sequence and its quality data, but has recently become the de facto standard for storing the output of high throughput sequencing instruments such as the Illumina Genome Analyzer.
In 2005, a study led by a researcher at the British Wellcome Trust Sanger Institute suggested that Giocangga might be the ancestor of over 1.5 million people, mostly in northeastern China and Mongolia.
Professor Gordon Dougan is Head of Pathogen Research and a member of the Board of Management at the Wellcome Trust Sanger Institute (WTSI) in Cambridge, United Kingdom.
Successively, she had two more experiences abroad as a visiting Professor at École Normale Supérieure, Paris, France (2001) and as visiting scientist at Wellcome Trust Sanger Institute, Hinxton, UK (2004-2005).
Tony Cox and Zemin Ning at the Wellcome Trust Sanger Institute, but became widely known through its implementation within the SAMtools software suite.
Massachusetts Institute of Technology | National Trust | National Trust for Places of Historic Interest or Natural Beauty | California Institute of Technology | Art Institute of Chicago | Institute for Advanced Study | American Institute of Architects | Georgia Institute of Technology | Rensselaer Polytechnic Institute | Rochester Institute of Technology | Franklin Institute | Royal Institute of Technology | Pasteur Institute | Institute of Contemporary Arts | California Institute of the Arts | Institute of Electrical and Electronics Engineers | British Film Institute | Pratt Institute | National Cancer Institute | Virginia Military Institute | Cato Institute | Australian Institute of Sport | Wellcome Trust | Illinois Institute of Technology | Curtis Institute of Music | American Institute of Aeronautics and Astronautics | Royal Institute of British Architects | National Institute of Standards and Technology | Monterrey Institute of Technology and Higher Education | Institute of Physics |
The Sanger Institute's Cancer Genome Project, first funded in 2005, focuses on DNA sequencing.
Researchers from the Wellcome Trust Sanger Institute reported that the mutation of CUX1 reduces the inhibitory effects of a biological inhibitor, PIK3IP1 (phosphoinositide-3-kinase interacting protein 1), resulted in higher activity of the growth promoting enzyme, phosphoinositide 3-kinase (PI3K) which leads to tumor progression.
The development of EuroPhenome is in collaboration with the Helmholtz Zentrum München, the Wellcome Trust Sanger Institute, and the Clinique de la Souris (France).
Established in September 2005, this international community includes representatives from a range of major sequencing and bioinformatics centres (including NCBI, EMBL, DDBJ, JCVI, JGI, EBI, Sanger, FIG) and research institutions.
The two main projects focused on complete cancer characterization in individuals, heavily involving sequencing include the Cancer Genome Project, based at the Wellcome Trust Sanger Institute and the Cancer Genome Atlas funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI).